Pfizer Inc.
PFE
$25.60
-$0.10-0.39%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.44% | -501.95% | -20.67% | -- | -4.75% |
| Total Depreciation and Amortization | -0.25% | -7.16% | -5.09% | -- | -6.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 115.29% | 134.56% | -48.81% | -- | 22.33% |
| Change in Net Operating Assets | 9.74% | -45.66% | -104.10% | -- | 42.48% |
| Cash from Operations | 11.99% | -20.43% | -31.44% | -- | 114.22% |
| Capital Expenditure | 22.70% | 7.85% | 7.53% | -- | 19.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.19% | 330.31% | -30.01% | -- | 57.55% |
| Cash from Investing | -76.02% | -278.68% | -18.13% | -- | 89.03% |
| Total Debt Issued | -- | 718.44% | -100.00% | -- | -- |
| Total Debt Repaid | 94.78% | 15.82% | 100.14% | -- | 32.71% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.33% | -2.73% | -2.69% | -- | -2.74% |
| Other Financing Activities | 20.22% | -214.29% | -550.00% | -- | 7.77% |
| Cash from Financing | 45.36% | 111.65% | 46.57% | -- | -6.00% |
| Foreign Exchange rate Adjustments | 371.43% | 117.24% | -77.78% | -- | 75.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 300.00% | -- | -- |
| Net Change in Cash | 50.53% | -337.78% | -1,134.48% | -- | 117.50% |